The Pain Controller
Dec 24, 2020
4 minutes
BY JOE C. MATHEW
PHOTOGRAPH BY MILIND SHELTE
Premchand Godha, Chairman and MD of Mumbai-based IPCA Laboratories was amused to hear US President Donald Trump term Hydroxychloroquine (HCQ) — a drug Trump claimed was helping him ward off Covid-19 — as an antimalarial medicine. The observation was outdated. HCQ, the drug Trump referred to, has not been sold anywhere in the world as an anti-malarial medicine for decades. It was introduced as a medicine for malaria 70 years ago, but is now used to treat rheumatoid arthritis.
Trump’s endorsement of HCQ gave a shot in the arm to IPCA, one of the leading global manufacturers of the time-tested, patent-expired drug. IPCA saw demand soar globally for a
You’re reading a preview, subscribe to read more.
Start your free 30 days